Press Releases KALA BIO, Inc. BOERSE MUENCHEN

Equities

27F0

US4831192020

Real-time BOERSE MUENCHEN Other stock markets 02:00:46 2024-07-09 am EDT			5-day change	1st Jan Change
6.405 ^EUR	-0.70%		-0.85%	-4.30%

Jun. 28	KALA BIO, Inc. announced that it has received $12.499192 million in funding from Baker Bros. Advisors LP, ADAR1 Capital Management, LLC, SR One Capital Management, LP	CI
Jun. 27	Top Midday Gainers	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

KALA BIO Announces $12,500,000 Private Placement	Jun. 27	AQ
KALA BIO : Corporate Overview - June 2024	Jun. 05	PU
KALA BIO to Present at Jefferies Global Healthcare Conference	May. 29	AQ
KALA BIO Reports First Quarter 2024 Financial Results and Provides Corporate Update	May. 14	AQ
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	Apr. 01	AQ
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	Mar. 29	AQ
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference	Feb. 26	AQ
KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference	Feb. 06	AQ
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	Jan. 19	AQ
KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update	Nov. 13	AQ
KALA BIO Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	23-09-21	AQ
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	23-09-20	AQ
KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference	23-09-05	AQ
KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update	23-08-07	AQ
KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update	23-08-04	AQ
Kala Pharmaceuticals : Certificate of Incorporation/Bylaws - Form 8-K	23-08-02	PU
KALA BIO to Participate in Upcoming Investor Conferences in August	23-08-02	AQ
Kala Pharmaceuticals Announces Name Change to KALA BIO	23-08-02	AQ
Kala Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(4)	23-07-20	AQ
Kala Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	23-07-19	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases KALA BIO, Inc. BOERSE MUENCHEN

Equities

27F0

US4831192020

Press Releases

Filters